Abstract:Managers choose to spend corporate resources to purchase directors' and officers' liability insurance, which protects directors and officers from personal financial liability in lawsuits brought against the firm and its directors and officers. We investigate whether the amount of D&O insurance coverage chosen by managers of IPO firms, and the cost of that insurance, is related to post-IPO abnormal stock price performance. If managers of IPO firms are exploiting superior inside information in bringing their companies public when the expected offering price exceeds managers' private valuation estimate, we hypothesize that the amount of insurance coverage chosen will be related to the post-offering performance of the issuing firm's shares. We analyze a sample of 72 IPO firms that went public between 1992 and 1996 for which we have detailed proprietary information about the amount and cost of D&O liability insurance. Consistent with the hypothesis, we find a significant negative relation between the 3-year post-IPO stock price performance and the amount of insurance coverage in place at the IPO date. We also analyze the pricing of D&O insurance by the insurers. Insurers charge more for insurance purchases that are larger than would be predicted by observable business risk proxies. However, insurers pool all abnormal insurance purchases together in that they do not distinguish between those who buy abnormally large insurance based on anticipated poor performance and those who buy extra insurance for other reasons (e.g., abnormally high risk aversion). Insurers do, however, appear to charge more to firms that buy more insurance and are subsequently sued, indicating that insurers are able to identify and price abnormal litigation risk. We argue that, similar to insider securities transactions, D&O insurance decisions reveal the private information of managers. This provides some motivation to argue that disclosure of the details of D&O insurance decisions, as is required in some other countries, is valuable.

Litigation risk and corporate philanthropy: A managerial perspective analysis

Corporate Philanthropy and Corporate Misconduct: Evidence from China

Navigating legal responsibilities in politically connected firms: Insights into the influence of directors' and officers' insurance on litigation risk

The impact of subscribing to directors' and officers' liability insurance on corporate financialization: Evidence from China

Costs may be a blessing in disguise: Litigation risk and greenwashing

Doing Good Deeds at a Constant Speed

The effect of directors' and officers' liabilities insurance on corporate social responsibility evidence from China

Corporate Social Responsibility and Directors' and Officers' Liability Risk: The Moderating Effect of Risk Environment and Growth Potential

Does shareholder litigation risk promote or hinder corporate social responsibility? A quasi‐natural experiment

Directors’ and Officers’ Liability Insurance: Evidence from Independent Directors’ Voting

Political Connections and Directors' and Officers' Liability Insurance – Evidence from China

How does directors' and officers' liability insurance affect green innovation? Evidence from China

Environmental Performance and Corporate Risk-Taking: Evidence from China

Confucianism and D&O insurance demand of Chinese listed companies

What protects me also makes me behave: The role of directors' and officers' liability insurance on empire-building managers in China

Directors' and officers' liability insurance and corporate environmental investment: empirical evidence from the most polluting Chinese listed firms

Directors' and officers' liability insurance and carbon emissions

Managerial Opportunism? Evidence from Directors' and Officers' Insurance Purchases

Directors' and officers' liability insurance, environmental regulation and firms' envi ronmental responsibility

Does directors' and officers' liability insurance induce empire building? Evidence from corporate labor investment

Directors' and officers' liability insurance and minority shareholders' participation in corporate governance